G Protein News and Research

RSS

Scientists reveal how thiostrepton blocks FOXM1 protein, prevents breast cancer development

Scientists have discovered how a molecule that was first discovered in bacteria blocks a protein which causes breast cancer to develop and spread, reveals research published in Nature Chemistry today.

22 Aug 2011

Quanterix's ELISA precisely measures low abundance cytokines in Crohn's disease

Quanterix Corporation, a company enabling a new generation of molecular diagnostic tests based on its revolutionary Single Molecule Array technology, today announced results of a pilot study to measure biomarkers of inflammation from patients with Crohn's disease.

20 Aug 2011

Two studies on how amino acids influence protein synthesis in recreational athletes

Physical activity requires strong, healthy muscles. Fortunately, when people exercise on a regular basis, their muscles experience a continuous cycle of muscle breakdown (during exercise) and compensatory remodeling and growth. Athletes have long experimented with methods to augment these physiologic responses to enhance muscle growth.

20 Aug 2011

High levels of calcium in coronary arteries increase risk of stroke, heart attack

The presence of calcium in coronary arteries is a much better predictor of heart attack and stroke than C-reactive protein among people with normal levels of LDL cholesterol, according to a study of more than 2,000 people led by a Johns Hopkins heart specialist.

19 Aug 2011

Seven research teams across the U.S. to develop new drugs for nervous system disorders

The National Institutes of Health has made awards to investigators across the United States for an ambitious set of projects seeking to develop new drugs for disorders of the nervous system.

19 Aug 2011

Powerful X-rays help develop new drug treatment for malignant melanoma

Powerful X-ray technology developed at the U.S. Department of Energy's (DOE's) national laboratories is revealing new insights into diseases ranging from Alzheimer's to the swine flu, and, most recently, enabled the discovery of a groundbreaking new drug treatment for malignant melanoma, the deadliest form of skin cancer.

19 Aug 2011

Researchers demonstrate a way to control excitation and contraction in cardiac muscle cells

By employing optogenetics, a new field that uses genetically altered cells to respond to light, and a tandem unit cell (TCU) strategy, researchers at Stony Brook University have demonstrated a way to control cell excitation and contraction in cardiac muscle cells, the details of which are published in the early online edition of Circulation: Arrhythmia & Electrophysiology: "Stimulating Cardiac Muscle by Light: Cardiac Optogenetics by Cell Delivery."

19 Aug 2011

Lucentis receives Health Canada approval for treatment of retinal vein occlusion

Following a priority review, Health Canada has approved Lucentis (ranibizumab) as a treatment for vision loss resulting from retinal vein occlusion (RVO). This makes Lucentis the first approved treatment of its class in Canada for this debilitating condition. Patients will now have access to a treatment that is proven to be effective and has an established safety profile.

18 Aug 2011

IU scientist to investigate salubrinal drug against osteoporosis

An Indiana University scientist studying human bone growth has received a $2.6 million grant from the U.S. Department of Defense to study a chemical compound with potential to fight osteoporosis and accelerate broken bone healing.

18 Aug 2011

Vitamin C shows promise against Alzheimer's disease

Researchers at Lund University have discovered a new function for vitamin C. Treatment with vitamin C can dissolve the toxic protein aggregates that build up in the brain in Alzheimer's disease.

18 Aug 2011

Milk helps children to stay hydrated during exercise than water

Active children need to be watered with milk. It's a more effective way of countering dehydration than a sports drink or water itself, say researchers at McMaster University.

18 Aug 2011

Two-color stimulated emission depletion microscopy in living cells

Researchers are able to achieve extremely high-resolution microscopy through a process known as stimulated emission depletion (STED) microscopy. This cutting-edge imaging system has pushed the performance of microscopes significantly past the classical limit, enabling them to image features that are even smaller than the wavelength of light used to study them.

18 Aug 2011

Researchers isolate 17 novel antibodies against HIV

A team of researchers at and associated with the International AIDS Vaccine Initiative (IAVI), The Scripps Research Institute, the biotechnology company Theraclone Sciences and Monogram Biosciences Inc., a LabCorp company, report in the current issue of Nature the isolation of 17 novel antibodies capable of neutralizing a broad spectrum of variants of HIV, the virus that causes AIDS.

18 Aug 2011

Some Muesli fattier than double quarter pounder

According to a consumer organization Choice, a morning bowl of muesli may contain as much fat as a McDonald's Double Quarter Pounder. The consumer organization tested 159 types of muesli and discovered that the popular breakfast meal isn't necessarily a healthy choice.

18 Aug 2011

FDA approves Zelboraf (vemurafenib) for advanced skin cancer

A new drug was approved for advanced skin cancer this Wednesday by U.S. regulators, offering the first new treatment for melanoma in 13 years.

18 Aug 2011

FDA approves Mayo Clinic's ovarian and breast cancer vaccines

Mayo Clinic has received investigational new drug approval from the Food and Drug Administration for two new cancer vaccines that mobilize the body's defense mechanisms to destroy malignant cells.

18 Aug 2011

Roche receives FDA approval for Zelboraf to treat BRAF mutation-positive metastatic melanoma

Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) approved Zelboraf (vemurafenib) for the treatment of BRAF V600E mutation-positive, inoperable or metastatic melanoma, as determined by an FDA-approved test.

18 Aug 2011

Zelboraf receives FDA approval for treatment of metastatic melanoma

The U.S. Food and Drug Administration today approved Zelboraf (vemurafenib), a drug to treat patients with late-stage (metastatic) or unresectable (cannot be removed by surgery) melanoma, the most dangerous type of skin cancer.

17 Aug 2011

Emergent commences TRU-016 Phase 1b/2 combination trial in relapsed indolent NHL

Emergent BioSolutions Inc. today announced the initiation of a Phase 1b/2 study (16011) of TRU-016 in combination with rituximab and bendamustine for patients with relapsed indolent non-Hodgkin's B-cell lymphomas, including follicular lymphoma, small lymphocytic lymphoma and marginal zone lymphoma.

17 Aug 2011

Study reveals structure of ribosomal assembly intermediate

As part of a joint research effort with the University of Michigan, scientists from the Florida campus of The Scripps Research Institute have for the first time defined the structure of one of the cell's most basic engines, which is required for cell growth, as it assembles from its components.

17 Aug 2011

G Protein News and Research

Scientists reveal how thiostrepton blocks FOXM1 protein, prevents breast cancer development

Quanterix's ELISA precisely measures low abundance cytokines in Crohn's disease

Two studies on how amino acids influence protein synthesis in recreational athletes

High levels of calcium in coronary arteries increase risk of stroke, heart attack

Seven research teams across the U.S. to develop new drugs for nervous system disorders

Powerful X-rays help develop new drug treatment for malignant melanoma

Researchers demonstrate a way to control excitation and contraction in cardiac muscle cells

Lucentis receives Health Canada approval for treatment of retinal vein occlusion

IU scientist to investigate salubrinal drug against osteoporosis

Vitamin C shows promise against Alzheimer's disease

Milk helps children to stay hydrated during exercise than water

Two-color stimulated emission depletion microscopy in living cells

Researchers isolate 17 novel antibodies against HIV

Some Muesli fattier than double quarter pounder

FDA approves Zelboraf (vemurafenib) for advanced skin cancer

FDA approves Mayo Clinic's ovarian and breast cancer vaccines

Roche receives FDA approval for Zelboraf to treat BRAF mutation-positive metastatic melanoma

Zelboraf receives FDA approval for treatment of metastatic melanoma

Emergent commences TRU-016 Phase 1b/2 combination trial in relapsed indolent NHL

Study reveals structure of ribosomal assembly intermediate

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News